BrewerNS. Antimicrobial agents—part II. The aminoglycosides. Mayo Clin Proc1977; 52: 675–9.
2.
YoungLSHewittWL. Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus. Antimicrob Agents Chemother1973; 4: 617–25.
3.
KlasterskyJDaneuDSwigsG, Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. J Infect Dis1974; 129: 189–93.
4.
FarchioneLAChudzikGM. Serum concentrations and inhibitory ratios during amikacin therapy of gram-negative infections. J Clin Pharmacol1978; 18: 432–8.
5.
FarchioneLA. Inactivation of aminoglycosides by penicillins. J Antimicrob Chemother1981; 8(Suppl A): 27–36.
6.
SchreinerGEMaherJF. Toxic nephropathy. Am J Med1965; 38: 409–49.
7.
SmithCRLipskyJJLaskinOL, Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med1980; 302: 1106–9.
8.
SmithCRBaughmanKEdwardsCQRogersJRLietmanPS. Controlled comparison of amikacin and gentamicin. N Engl J Med1977; 296: 349–53.
9.
LauWKYoungLSBlackRE, Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients. Am J Med1977; 62: 959–66.
10.
NeuHBendushC.Ototoxicity of tobramycin: A clinical overview. J Infect Dis1976; 134(Suppl): S206–18.
11.
LaneAZWrightGEBlairDC. Ototoxicity and nephrotoxicity of amikacin. Am J Med1977; 62: 911–8.
BlackRELauWKWeinsteinRJYoungLSHewittWL. Ototoxicity of amikacin. Antimicrob Agents Chemother1976; 9: 956–61.
14.
MeyerRDLewisRPCarmaltEDFinegoldSM. Amikacin therapy for serious gram-negative bacillary infections. Ann Intern Med1975; 83: 790–800.
15.
TallyFPLouieTJWeinsteinWMBartlettJGGorbachSL. Amikacin therapy for severe gram-negative sepsis. Ann Intern Med1975; 83: 484–8.
16.
ValdiviesoMFeldRRodriguezVBodeyGP. Amikacin therapy of infections in neutropenic patients. Am J Med Sci1975; 270: 453–63.
17.
TallyFPLouieTJO'KeefeJPGorbachSLBartlettJG. Amikacin therapy for severe gram-negative sepsis: Efficacy in infections involving gentamicin resistant organisms. J Infect Dis1976; 134(Suppl): S428–32.
18.
MathiasRGRonaldARGurwithMJ, Clinical evaluation of amikacin in the treatment of infections due to gram-negative aerobic bacilli. J Infect Dis1976; 134(Suppl): S394–401.
19.
LernerSASeligsohnRMatzGJ. Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin. Am J Med1977: June (symposium issue): 113–7.
20.
BenderJFFortnerCLSchimpffSC, Comparative auditory toxicity of aminoglycoside antibiotics in leukopenic patients. Am J Hosp Pharm1979; 36: 1083–7.
21.
FeeWEVierraVLathropGR. Clinical evaluation of aminoglycoside toxicity: Tobramycin versus gentamicin, a preliminary report. J Antimicrob Chemother1978; 4(Suppl): 31–6.
KeysTFKurtzSBJonesJDMullerSM. Renal toxicity during therapy with gentamicin or tobramycin. Mayo Clin Proc1981; 56: 556–9.
24.
FongIWFentonRSBirdR.Comparative toxicity of gentamicin versus tobramycin: A randomized prospective study. J Antimicrob Chemother1981; 7: 81–8.
25.
FeldRValdiviesoMBodeyGPRodriguezV.Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer. J Infect Dis1977; 135: 61–6.
26.
GreeneWHIsturizRHarmonARootRKAndrioleVT. Comparative aminoglycoside toxicity: A prospective, randomized comparison of carbenicillin in combination with gentamicin, tobramycin, amikacin or netilmicin. 12th International Congress of Chemotherapy, Florence, Italy, July 19–24, 1981.
27.
KuminGD. Clinical nephrotoxicity of tobramycin and gentamicin. JAMA1980; 244: 1808–10.
28.
EmmersonAMReevesDSRibberDMDWiseR.Nephrotoxicity with gentamicin or tobramycin. Lancet1980; 1: 96.
29.
EpsteinFH. Commentary on tobramycin vs. gentamicin nephrotoxicity: Is there a difference?. Int Med Alert1980; 2: 21–2.
30.
LevyPC. Toxicity of gentamicin and tobramycin (letter). N Engl J Med1980; 303: 1002.